HomeCompareMCK vs NKE

MCK vs NKE: Dividend Comparison 2026

MCK yields 0.38% · NKE yields 3.16%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NKE wins by $1.81M in total portfolio value
10 years
MCK
MCK
● Live price
0.38%
Share price
$860.19
Annual div
$3.28
5Y div CAGR
66.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.3K
Annual income
$10,761.37
Full MCK calculator →
NKE
NKE
● Live price
3.16%
Share price
$51.24
Annual div
$1.62
5Y div CAGR
66.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.85M
Annual income
$1,337,341.87
Full NKE calculator →

Portfolio growth — MCK vs NKE

📍 NKE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMCKNKE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MCK + NKE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MCK pays
NKE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCK
Annual income on $10K today (after 15% tax)
$32.41/yr
After 10yr DRIP, annual income (after tax)
$9,147.16/yr
NKE
Annual income on $10K today (after 15% tax)
$268.74/yr
After 10yr DRIP, annual income (after tax)
$1,136,740.59/yr
At 15% tax rate, NKE beats the other by $1,127,593.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCK + NKE for your $10,000?

MCK: 50%NKE: 50%
100% NKE50/50100% MCK
Portfolio after 10yr
$948.0K
Annual income
$674,051.61/yr
Blended yield
71.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NKE right now

MCK
Analyst Ratings
1
Strong
24
Buy
6
Hold
Consensus: Buy
Price Target
$982.38
+14.2% upside vs current
Range: $900.00 — $1,085.00
Altman Z
5.9
Piotroski
7/9
NKE
Analyst Ratings
1
Strong
42
Buy
23
Hold
4
Sell
Consensus: Buy
Price Target
$75.35
+47.1% upside vs current
Range: $62.00 — $110.00
Altman Z
3.8
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCK buys
0
NKE buys
0
No recent congressional trades found for MCK or NKE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMCKNKE
Forward yield0.38%3.16%
Annual dividend / share$3.28$1.62
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR66.7%66.3%
Portfolio after 10y$44.3K$1.85M
Annual income after 10y$10,761.37$1,337,341.87
Total dividends collected$22.6K$1.78M
Payment frequencyquarterlyquarterly
SectorHealthcareConsumer Discretionary
Analyst consensusBuyBuy
Analyst price target$982.38$75.35

Year-by-year: MCK vs NKE ($10,000, DRIP)

YearMCK PortfolioMCK Income/yrNKE PortfolioNKE Income/yrGap
1← crossover$10,764$63.56$11,226$525.77$462.00NKE
2$11,624$106.59$12,929$917.32$1.3KNKE
3$12,617$179.33$15,476$1,642.01$2.9KNKE
4$13,803$303.26$19,614$3,054.78$5.8KNKE
5$15,286$516.89$27,004$6,017.26$11.7KNKE
6$17,248$891.81$41,770$12,875.77$24.5KNKE
7$20,023$1,567.70$75,648$30,954.02$55.6KNKE
8$24,260$2,835.35$168,071$87,127.77$143.8KNKE
9$31,310$5,352.05$480,693$300,856.83$449.4KNKE
10$44,263$10,761.37$1,851,684$1,337,341.87$1.81MNKE

MCK vs NKE: Complete Analysis 2026

MCKHealthcare

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Full MCK Calculator →

NKEConsumer Discretionary

NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells men's, women's, and kids athletic footwear, apparel, equipment, and accessories worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks. In addition, it sells a line of performance equipment and accessories comprising bags, socks, sport balls, eyewear, timepieces, digital devices, bats, gloves, protective equipment, and other equipment for sports activities under the NIKE brand; and various plastic products to other manufacturers. The company markets apparel with licensed college and professional team, and league logos, as well as sells sports apparel. Additionally, it licenses unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. The company sells its products to footwear stores; sporting goods stores; athletic specialty stores; department stores; skate, tennis, and golf shops; and other retail accounts through NIKE-owned retail stores, digital platforms, independent distributors, licensees, and sales representatives. The company was formerly known as Blue Ribbon Sports, Inc. and changed its name to NIKE, Inc. in 1971. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.

Full NKE Calculator →
📬

Get this MCK vs NKE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCK vs SCHDMCK vs JEPIMCK vs OMCK vs KOMCK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.